Dr Joseph F Territo, MD - Medicare Ophthalmology in Mc Lean, VA

Dr Joseph F Territo, MD is a medicare enrolled "Ophthalmology" physician in Mc Lean, Virginia. His current practice location is 8008 Westpark Dr, Mc Lean, Virginia. You can reach out to his office (for appointments etc.) via phone at (703) 287-6400.

Dr Joseph F Territo is licensed to practice in Virginia (license number 0101052508) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1578639803.

Contact Information

Dr Joseph F Territo, MD
8008 Westpark Dr,
Mc Lean, VA 22102-3109
(703) 287-6400
(703) 922-1111



Physician's Profile

Full NameDr Joseph F Territo
GenderMale
SpecialityOphthalmology
Location8008 Westpark Dr, Mc Lean, Virginia
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1578639803
  • Provider Enumeration Date: 11/28/2006
  • Last Update Date: 11/22/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 5294718995
  • Enrollment ID: I20040612000070

Medical Identifiers

Medical identifiers for Dr Joseph F Territo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1578639803NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology D0055492 (Maryland)Secondary
207W00000XOphthalmology MD20697 (District Of Columbia)Secondary
207W00000XOphthalmology 0101052508 (Virginia)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Joseph F Territo allows following entities to bill medicare on his behalf.
Entity NameKaiser Foundation Health Plan Of The Mid-atlantic States,inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952461816
PECOS PAC ID: 3779495858
Enrollment ID: O20040105000308

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more Medical News

› Verified 7 days ago

Entity NameKaiser Foundation Health Plan Of The Mid-atlantic States,inc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1578638425
PECOS PAC ID: 3779495858
Enrollment ID: O20040805001280

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more Medical News

› Verified 7 days ago

Entity NameKaiser Foundation Health Plan Of The Mid-atlantic States,inc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1073678637
PECOS PAC ID: 3779495858
Enrollment ID: O20100729000796

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more Medical News

› Verified 7 days ago

Entity NameKaiser Foundation Health Plan Of The Mid-atlantic States,inc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1366781700
PECOS PAC ID: 3779495858
Enrollment ID: O20130507000207

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more Medical News

› Verified 7 days ago

Entity NameKaiser Foundation Health Plan Of The Mid-atlantic States,inc
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1497023188
PECOS PAC ID: 3779495858
Enrollment ID: O20131029000108

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Joseph F Territo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Joseph F Territo, MD
2101 East Jefferson Street, Ppqa Medicare Compliance Unit 6 West,
Rockville, MD 20852-4908

Ph: (301) 816-6660
Dr Joseph F Territo, MD
8008 Westpark Dr,
Mc Lean, VA 22102-3109

Ph: (703) 287-6400

News Archive

Researchers develop new implantable metamaterials to destroy cancerous tissue

The research, reported online July 21, 2010, in the journal Advanced Materials, provides a promising path towards the development of a new class of metamaterial-inspired implantable biosensors and biodetectors.Metamaterials are artificial electromagnetic composites, typically made of highly conducting metals, whose structures respond to electromagnetic waves in ways that atoms in natural materials do not. The most futuristic metamaterials would absorb all light, to create heat to destroy cancerous tissue, or bend light completely around an object, rendering that object invisible-an imaginary delight for fans of science fiction or spy novels.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

Vaccinogen chooses Clinipace Worldwide to manage pivotal phase 3b confirmatory trial for OncoVAX

Clinipace Worldwide, a global full-service clinical research organization (CRO), announced today that Vaccinogen, a biotechnology company with more than three decades experience researching how to combat cancer using the body's own immune system, has selected the company to manage a pivotal phase 3b confirmatory trial for OncoVAX in the treatment of Stage II Colon Cancer.

Current hospital tests for Clostridium difficile not accurate enough

Current hospital tests for the bacterium Clostridium difficile (C difficile) are not accurate enough and a new two-stage process should be introduced to avoid misdiagnosis and its consequences.

Function of stem cells in blood-forming system is regulated by estrogen, says study

Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system — which is similar in both sexes — also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal.

Read more News

› Verified 7 days ago


Ophthalmology Doctors in Mc Lean, VA

Andrew E. Holzman, M.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 1750 Tysons Blvd Ste 120, Mc Lean, VA 22102
Phone: 703-556-9155    
Paul Joseph Connors, M.D., J.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 6142 Chesterbrook Rd, Mc Lean, VA 22101
Phone: 703-893-9866    
Claudia Sieger Cohen, MD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 6845 Elm St, Mc Lean, VA 22101
Phone: 703-356-6880    
Dr. Robert Alan Caine, M.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 6510 W Langley Ln, Mc Lean, VA 22101
Phone: 703-821-2020    
Mr. Michael Carmine Tigani, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 6845 Elm St, Suite 250, Mc Lean, VA 22101
Phone: 703-356-5484    Fax: 703-356-2223
Kim Jiramongkolchai, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102
Phone: 703-287-6400    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.